Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Data on diabetes drug links to cancer withheld says investigation

BMJ and Channel 4 say access to raw trial data would help resolve uncertainly about GLP-1 agonists

- PMLiVE

Ben Goldacre: No escape from trial transparency

Bad Pharma author says AllTrials and new European legislation make data disclosure unavoidable

Roche - Basel

EU approves new use of Roche’s RoActemra in children

Swiss pharma firm hopes to increase revenue from arthritis drug to tip it into blockbuster status

- PMLiVE

Boehringer says faldaprevir does well in Asian hepatitis C patients

Trial success in patients from Korea, Japan and Taiwan

- PMLiVE

mHealth could cut EU’s chronic disease costs

Mobile operators association says compliance and monitoring could be improve through technology

Pharma deals during May 2013

Deal Watch: Major pharma collaborations, acquisitions and agreements in the past month

Deal Watch table for May 2013

Table listing all the major pharma mergers, acquisitions and collaborations in the past month

- PMLiVE

Data control: pharma and big data in healthcare

Whether it's big, smart or right, this could be the year pharma and healthcare sees large benefits from data

- PMLiVE

PAN bolsters team with two hires and three promotions

New roles go to the creative agency's Natalie Enniks, Naumaan Mayet and Lawrence Clift

- PMLiVE

FDA panel says Avandia restrictions should be eased

Vote backs wider use of GSK's drug in diabetes

- PMLiVE

­Pfizer signs $635m deal with CytomX for cancer ADCs

Will use biotech's Probody technology to develop antibody-drug conjugates

National Institute for Health and Care Excellence NICE logo

NICE backs Abilify for teenagers with bipolar disorder

Otsuka's antisphycotic recommended for use in adolescents in England and Wales

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links